Researchers sell secrets to Wall Street investors

Luke Timmerman and David Heath of The Seattle Times use sources and documents to investigate at least 26 claims that drug researchers leaked secrets to Wall Street. "In 24 of the 26 cases, the firms issued reports to select clients with detailed information obtained from doctors involved in confidential studies. The reports advised clients whether to buy or sell a drug stock." A sidebar on how this is done is included, as well as information on how the story was reported. The investigation has already sparked an SEC investigation.